Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

The New York Times Company, together with its subsidiaries, provides news and information for readers and viewers across various platforms worldwide. It offers The New York Times (The Times), a daily and Sunday newspaper in the United States, as well as international edition of The Times; and operates the NYTimes.com Website. The company also transmits articles, graphics, and photographs from The Times and other publications to approximately 1,500 newspapers, magazines, and websites; licenses electronic databases to resellers in the business, professional, and library markets; and offers magazine licensing, news digests, book development, and rights and permissions. In addition, it engages in the live events business, which hosts physical and virtual live events to connect audiences with journalists and outside thought leaders; direct-sold website, mobile application, podcast, email, and video advertisements, as well as digital advertising services; operates Wirecutter, a product review and recommendation products; develops mobile applications, including games and cooking products; prints and distributes products for third parties; and offers other products and services. The company was founded in 1851 and is headquartered in New York, New York.

The New York Times Company

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 24, 2025) - DEALMAKER SPORTS, THE DIVISION OF DEALMAKER PIONEERING FAN-LED OWNERSHIP IN SPORTS, TODAY ANNOUNCED A STRATEGIC COLLABORATION WITH XTREME ONE ENTERTAINMENT, THE PUBLICLY TRADED COMPANY FOCUSED ON LIVE SPORTS, ENTERTAINMENT, AND EVENT MARKETING, AND WHICH IS THE PARENT COMPANY OF XTREME FIGHTING CHAMPIONSHIPS (XFC). FANS WILL HAVE UNPRECEDENTED ACCESS TO INVEST IN THE EVOLUTION OF ONE OF THE WORLD'S MOST DYNAMIC FIGHT LEAGUES.

DEALMAKER SPORTS AND XTREME ONE JOIN FORCES TO BRING FAN OWNERSHIP TO THE FIGHT GAME

COMPANY MAKING PROGRESS TOWARD EVENTUAL COMMERCIALIZATION OF THE PUMP, WHICH IS DESIGNED FOR DEPLOYMENT IN ADVANCED SMALL AND MICRO MODULAR REACTOR DESIGNS NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 19, 2025) - NANO NUCLEAR ENERGY INC. (NASDAQ: NNE) ("NANO NUCLEAR" OR "THE COMPANY"), A LEADING ADVANCED NUCLEAR MICRO MODULAR REACTOR AND TECHNOLOGY COMPANY FOCUSED ON DEVELOPING CLEAN ENERGY SOLUTIONS, TODAY ANNOUNCED THAT IT HAS EXECUTED THE FIRST FULL TESTS OF ITS PROPRIETARY, PATENT PENDING ANNULAR LINEAR INDUCTION PUMP (ALIP) AT UP TO 350OC FLUID TEMPERATURE AT THE COMPANY'S DEMONSTRATION FACILITY IN WESTCHESTER COUNTY, NEW YORK. THE ALIP FUNCTIONS AS A THERMAL MANAGEMENT AND DISTRIBUTION SYSTEM INTENDED TO COMPLIMENT ADVANCED NUCLEAR ENERGY PLATFORMS UTILIZING HIGH BOILING-POINT, HIGH THERMAL-CONDUCTIVITY COOLANTS, SUCH AS MOLTEN SALTS, LEAD EUTECTICS, AND LIQUID METALS.

NANO NUCLEAR COMPLETES INITIAL FULL-SYSTEM TESTING OF ITS PATENT-PENDING, PROPRIETARY ANNULAR LINEAR INDUCTION PUMP TECHNOLOGY VALIDATING KEY DESIGN FEATURES DESIGNED FOR LONG-TERM OPERATIONAL DURABILITY

TYPE C MEETING WITH US FDA SET FOR DECEMBER 11, 2025 TO ADDRESS KEY ITEMS FOLLOWING AUGUST 27, 2025 END OF PHASE 2 MEETING REGARDING PHASE 2B CLINICAL TRIAL OF OST-HER2: PREVENTION OR DELAY OF RECURRENT, FULLY-RESECTED PULMONARY METASTATIC OSTEOSARCOMA US BIOLOGICS LICENSING APPLICATION (BLA) AND UK MHRA MARKETING AUTHORIZATION APPLICATION FILINGS FOR OST-HER2 EXPECTED IN JANUARY 2025 LEVERAGING PROJECT ORBIS UK MHRA PRE-MARKETING AUTHORIZATION APPLICATION (MAA) MEETING SCHEDULED FOR DECEMBER 8, 2025; EMA PRE-MAA MEETING REQUEST NOW GRANTED, AWAITING SCHEDULING $7.8 MILLION WARRANT EXERCISE INDUCEMENT ALLOWED FOR KEY ONE-TIME REGULATORY-RELATED PAYMENTS AND PROVIDED COMPANY WITH CAPITAL INTO LATE 2026 BY DELAYING LAUNCH TO 2027 COMPANY REMAINS ELIGIBLE TO RECEIVE PRIORITY REVIEW VOUCHER (PRV) BASED ON PEDIATRIC RARE PEDIATRIC DISEASE DESIGNATION (RPDD) FOR OSTEOSARCOMA IF APPROVED BY SEPTEMBER 30, 2026 NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 17, 2025) - OS THERAPIES INC. (NYSE AMERICAN: OSTX) ("OS THERAPIES" OR "THE COMPANY"), THE WORLD LEADER IN LISTERIA-BASED CANCER IMMUNOTHERAPIES, TODAY REPORTED THIRD QUARTER 2025 FINANCIAL RESULTS FOR THE PERIOD ENDED SEPTEMBER 30, 2025 AND PROVIDED A BUSINESS UPDATE. "THE NEXT SIX TO TWELVE MONTHS WILL BE TRANSFORMATIVE FOR OS THERAPIES," SAID PAUL ROMNESS, MPH, CHAIRMAN & CEO OF OS THERAPIES.

OS THERAPIES REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 6, 2025) - DEALMAKER, NORTH AMERICA'S LARGEST RETAIL CAPITAL-RAISING PLATFORM, HAS RAISED $20

DEALMAKER RAISES $20M TO DRIVE GROWTH AND TRANSFORM CAPITAL RAISING

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 6, 2025) - IF YOU SUFFERED A LOSS ON YOUR MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ:

LEVI & KORSINSKY NOTIFIES MOONLAKE IMMUNOTHERAPEUTICS (MLTX) INVESTORS - LEAD PLAINTIFF DEADLINE ON DECEMBER 15, 2025

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 6, 2025) - IF YOU SUFFERED A LOSS ON YOUR JAMES HARDIE INDUSTRIES

LEVI & KORSINSKY URGES JAMES HARDIE INDUSTRIES PLC. (JHX) SHAREHOLDERS TO ACT BEFORE LEAD PLAINTIFF DEADLINE DECEMBER 23, 2025

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 6, 2025) - IF YOU SUFFERED A LOSS ON YOUR WPP PLC (NYSE:

INVESTORS IN WPP PLC (WPP): PROTECT YOUR RIGHTS - CONTACT LEVI & KORSINSKY BEFORE DECEMBER 8, 2025

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 6, 2025) - IF YOU SUFFERED A LOSS ON YOUR ATYR PHARMA, INC

INVESTORS IN ATYR PHARMA, INC. (ATYR): PROTECT YOUR RIGHTS - CONTACT LEVI & KORSINSKY BEFORE DECEMBER 8, 2025

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 6, 2025) - IF YOU SUFFERED A LOSS ON YOUR BAXTER INTERNATIONAL, INC

LEVI & KORSINSKY URGES BAXTER INTERNATIONAL, INC. (BAX) SHAREHOLDERS TO ACT BEFORE LEAD PLAINTIFF DEADLINE DECEMBER 15, 2025

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 5, 2025) - IF YOU SUFFERED A LOSS ON YOUR CARMAX, INC. (NYSE:

LEVI & KORSINSKY URGES CARMAX, INC. (KMX) SHAREHOLDERS TO ACT BEFORE LEAD PLAINTIFF DEADLINE JANUARY 2, 2026

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 5, 2025) - SETT AND LUCAS, A LEADING GLOBAL INVESTMENT BANK SPECIALIZING IN

SETT & LUCAS ADVISES CREOVAI ON THE SALE TO CAPACITY

NEW YORK--(BUSINESS WIRE)--THE NEW YORK TIMES COMPANY (NYSE: NYT) ANNOUNCED TODAY THAT ITS THIRD-QUARTER 2025 FINANCIAL RESULTS ARE AVAILABLE ON THE NEW YORK TIMES COMPANY'S INVESTOR RELATIONS WEBSITE AT INVESTORS.NYTCO.COM. AS PREVIOUSLY ANNOUNCED, THE NEW YORK TIMES COMPANY WILL HOST ITS EARNINGS CONFERENCE CALL TODAY AT 8:00 A.M. E.T. TO DISCUSS THESE RESULTS. A LIVE WEBCAST OF THE EARNINGS CONFERENCE CALL WILL BE AVAILABLE AT INVESTORS.NYTCO.COM. PARTICIPANTS CAN PRE-REGISTER FOR THE TELEPH.

THE NEW YORK TIMES COMPANY REPORTS THIRD-QUARTER 2025 RESULTS

NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 4, 2025) - LEVI AND KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMMENCED AN

DID YOU SUFFER LOSSES IN F5, INC. (FFIV)? CONTACT LEVI & KORSINSKY ABOUT SECURITIES FRAUD CLAIMS

NEW YORK, NY, OCT. 24, 2025 (GLOBE NEWSWIRE) -- ATTHE CAPITAL LINKWE ANNOUNCED AN INVESTIGATION INTO REVIEWING THE PUBLIC RECORD OF LUXURBAN HOTELS INC. (THE DEBTOR) BEFORE THE UNITED STATES BANKRUPTCY COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, WE THINK THE FOLLOWING CLARIFICATION CONCERNING BISNOW'S DEPUTY DIP ETHAN ROTHSTEIN'S ARTICLE DATED OCTOBER 23, 2025, TITLED LUXURBAN HOTELS TO LIQUIDATE AS BANKRUPTCY CLAIMS SURPASS $123 MILLION.

THE CAPITAL LINK INVESTIGATES STATEMENTS REGARDING MISCHARACTERIZATIONS IN BISNOW'S COVERAGE OF LUXURBAN HOTELS

NEW YORK, NY, OCT. 22, 2025 (GLOBE NEWSWIRE) -- A PANEL OF LEGAL, FINANCIAL, AND TECHNOLOGY EXPERTS BYNY ARTISINALHAS ISSUED AN EXTENSIVE ANALYSIS TITLED THE STATUTORY FALLACY OF APPLYING NEW YORK STATE AND CITY TAXATION TO LUXURBAN HOTELS INC. THE PANEL CONCLUDES THAT CLAIMS SUGGESTING LUXURBAN OWES LARGE-SCALE TAX LIABILITIES IN NEW YORK AND SEEMS LIKE IT MAY BE INACCURATE, LEGALLY PRECLUDED UNDER BOTH STATE AND CITY LAW, AND FUNDAMENTALLY INCONSISTENT WITH ESTABLISHED OTA PAYMENT SYSTEMS.

NY ARTISINAL EXAMINES TAX EXPOSURE CLAIMS AGAINST LUXURBAN HOTELS INC., CITING OTA PAYMENT AND TAX COLLECTION LAWS

- GLOBAL CAMPAIGN CELEBRATES THE U.S. DEBUT OF THE MOVIE-INSPIRED COLLABORATION PACKAGE - NEW YORK , OCT. 20, 2025 /PRNEWSWIRE/ -- NONGSHIM CARRIED OUT A GLOBAL CAMPAIGN AT NEW YORK TIMES SQUARE TO CELEBRATE THE LAUNCH OF SHIN RAMYUN IN COLLABORATION WITH NETFLIX'S HIT ANIMATED FILM 'KPOP DEMON HUNTERS'. AS KNOWN FOR "THE CROSSROADS OF THE WORLD" AND ATTRACTING OVER 450,000 VISITORS DAILY, TIMES SQUARE SERVED AS THE STAGE FOR GLOBAL CONSUMERS TO DIRECTLY TASTE AND ENJOY THE SHIN RAMYUN BRAND THROUGH A VARIETY OF INTERACTIVE ACTIVITIES THAT SEAMLESSLY CONNECTED BOTH ONLINE AND OFFLINE EXPERIENCES.

NONGSHIM SHIN RAMYUN LIGHT UPS NEW YORK TIMES SQUARE WITH 'KPOP DEMON HUNTERS'

NEW YORK, NY, OCT. 16, 2025 (GLOBE NEWSWIRE) -- THE CAPITAL LINK TODAY ANNOUNCED THE PUBLICATION OF A NEW INDEPENDENT ANALYSIS EXAMINING LUXURBAN HOTELS INC.'S COMPLIANCE WITH NEW YORK STATE AND CITY SALES AND OCCUPANCY TAX REQUIREMENTS. THE REPORT, TITLEDTHEY GOT IT WRONG,REVIEWS STATUTORY LAW, AUDITED FILINGS, AND RELEVANT ENFORCEMENT RECORDS COVERING THE PERIOD 20202025. THE CAPITAL LINK'S ANALYSIS FINDS THAT LUXURBAN'S NEW YORK TAX POSITION IS CONSISTENT WITH APPLICABLE STATE AND CITY LAW AND ENFORCEMENT OUTCOMES. IN PARTICULAR, THE REPORT HIGHLIGHTS THAT A SUBSTANTIAL PORTION OF TAXABLE TRANSACTIONS WERE PROCESSED AND REMITTED THROUGH THIRD-PARTY ONLINE TRAVEL AGENCIES (OTAS), WHICHUNDER NEW YORK LAWARE OFTEN RESPONSIBLE FOR COLLECTING AND REMITTING SALES AND OCCUPANCY TAXES. THE ANALYSIS FURTHER NOTES THAT LUXURBAN'S FILINGS AND THE CITY OF NEW YORK'S SETTLEMENT RECORDS ARE CONSISTENT WITH COMPLIANCE AND DO NOT SUPPORT RECENT CLAIMS OF LARGE UNPAID-TAX LIABILITIES. OUR OBJECTIVE IS TO BRING CLARITY TO A TECHNICAL BUT IMPORTANT ISSUE: WHETHER THE LAW, FILINGS, AND ENFORCEMENT RECORDS SUPPORT CLAIMS OF SIGNIFICANT UNPAID TAXES, SAID A CAPITAL LINK SPOKESPERSON. THE INDEPENDENT EVIDENCE INDICATES COMPLIANCE AND SUGGESTS THAT SOME PUBLIC NARRATIVES HAVE OVERSTATED POTENTIAL LIABILITIES. THE REPORT ALSO DISCUSSES THE BROADER IMPLICATIONS FOR HOSPITALITY TAX REPORTING AND INVESTOR INFORMATION, STRESSING THE IMPORTANCE OF CAREFUL INTERPRETATION OF FILINGS AND ENFORCEMENT ACTIONS. THE FULL REPORT, THEY GOT IT WRONG: A LEGAL AND FINANCIAL ANALYSIS OF LUXURBAN HOTELS' SALES-TAX COMPLIANCE IN NEW YORK, IS AVAILABLE AT: HTTPS://THECAPITALLINK.COM/REPORTS/LUXURBAN-TAX-ANALYSIS ABOUT THE CAPITAL LINKTHE CAPITAL LINK IS AN INDEPENDENT RESEARCH FIRM DELIVERING LEGAL, FINANCIAL, AND POLICY ANALYSIS FOR INVESTORS, POLICYMAKERS, AND THE PUBLIC.

THE CAPITAL LINK ISSUES INDEPENDENT ANALYSIS ON LUXURBAN HOTELS' NEW YORK SALES-TAX COMPLIANCE

NEW YORK, USA, OCT. 15, 2025 (GLOBE NEWSWIRE) -- GLOBAL SMART MEDICAL DEVICES MARKET POISED TO EXPAND AT A CAGR OF ~12% WITH TECHNOLOGICAL ADVANCEMENTS AND INCREASED ADOPTION | DELVEINSIGHT THE SMART MEDICAL DEVICES MARKET IS EXPERIENCING RAPID GROWTH, DRIVEN BY INCREASING DEMAND FOR REMOTE PATIENT MONITORING, WEARABLE HEALTH TECHNOLOGIES, AND REAL-TIME DATA ANALYTICS.

GLOBAL SMART MEDICAL DEVICES MARKET POISED TO EXPAND AT A CAGR OF ~12% WITH TECHNOLOGICAL ADVANCEMENTS AND INCREASED ADOPTION | DELVEINSIGHT

ONLY AIRLINE WITH NONSTOPS FROM NEWARK/NEW YORK TO SPLIT, CROATIA; GLASGOW, SCOTLAND AND SANTIAGO DE COMPOSTELA, SPAIN ONLY U.S. AIRLINE WITH NONSTOPS BETWEEN NEWARK/NEW YORK AND BARI, ITALY; SEOUL, SOUTH KOREA, AS WELL AS NEW, DAILY FLIGHTS FROM WASHINGTON-DULLES TO REYKJAVIK, ICELAND AIRLINE ADDS THIRD ADDITIONAL SERVICE BETWEEN TEL AVIV, ISRAEL AND NEWARK/NEW YORK  ENHANCING CONVENIENCE FOR CUSTOMERS AND REINFORCING UNITED'S POSITION AS THE LARGEST U.S. CARRIER TO ISRAEL UNITED REMAINS THE LARGEST CARRIER ACROSS THE ATLANTIC WITH SERVICE TO 46 CITIES PLANNED FOR NEXT YEAR INCLUDING ALL SIX NEW ATLANTIC DESTINATIONS FROM RECORD SUMMER 2025 INTERNATIONAL EXPANSION TICKETS FOR ALL THESE NEW FLIGHTS ARE ON SALE TODAY CHICAGO , OCT. 9, 2025 /PRNEWSWIRE/ -- UNITED AIRLINES TODAY ANNOUNCED ITS SUMMER 2026 SCHEDULE WITH SERVICE TO FOUR NEW CITIES ACROSS CROATIA, ITALY, SCOTLAND AND SPAIN  LEADING THE WAY WITH THE MOST DESTINATIONS ACROSS THE ATLANTIC THAN ANY U.S. CARRIER. IN SUMMER 2026, UNITED WILL BE THE ONLY U.S. AIRLINE TO LAUNCH NONSTOP FLIGHTS TO FOUR NEW DESTINATIONS FROM ITS HUB INNEWARK/NEW YORKTO SPLIT, CROATIA; BARI,ITALY; GLASGOW, SCOTLAND AND SANTIAGO DE COMPOSTELA,SPAIN.

UNITED ADDS FLIGHTS TO NEW CITIES IN CROATIA, ITALY, SCOTLAND AND SPAIN NEXT SUMMER

OVERALL SURVIVAL RECOGNIZED AS KEY EFFICACY ENDPOINT IN OSTEOSARCOMA, WHERE NO STANDARD OF CARE EXISTS RAPPORTEUR HIGHLIGHTS POTENTIAL BROADER BENEFITS OF OST-HER2 IN PULMONARY AND PRIMARY OSTEOSARCOMA SETTINGS, SUPPORTED BY TRANSLATIONAL CANINE DATA FROM THE UNIVERSITY OF PENNSYLVANIA NEW YORK, NEW YORK--(NEWSFILE CORP. - OCTOBER 9, 2025) - OS THERAPIES INC. (NYSE AMERICAN: OSTX) ("OS THERAPIES" OR "THE COMPANY"), A CLINICAL-STAGE CANCER IMMUNOTHERAPY AND ANTIBODY DRUG CONJUGATE BIOTECHNOLOGY COMPANY, TODAY ANNOUNCED A POSITIVE REGULATORY UPDATE FOLLOWING AN OCTOBER 6, 2025 MEETING WITH ITS EUROPEAN MEDICINES AGENCY (EMA) RAPPORTEUR, THE DUTCH MEDICINES EVALUATION BOARD (MEB). DURING THE MEETING, OS THERAPIES AND THE DUTCH RAPPORTEUR ALIGNED ON KEY AREAS, INCLUDING SAFETY, NON-CLINICAL AND CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DATA IN SUPPORT OF THE COMPANY'S ONGOING OST-HER2 PHASE 2B CLINICAL TRIAL IN THE PREVENTION OR DELAY OF RECURRENT, FULLY-RESECTED, PULMONARY METASTATIC OSTEOSARCOMA.

OS THERAPIES PROVIDES POSITIVE EMA REGULATORY UPDATE FOLLOWING POSITIVE RAPPORTEUR MEETING

DAYTIME EMMY AWARDS PARTICIPATION - 2 NOMINATION FOR 'SHELTER ME: CANCER PIONEERS' COMPARATIVE ONCOLOGY DOCUMENTARY THAT FEATURES CLINICIANS, VETERINARIANS AND HUMAN & CANINE PATIENTS WHO PARTICIPATED IN OST-HER2 CLINICAL TRIALS NEW YORK, NEW YORK--(NEWSFILE CORP. - OCTOBER 7, 2025) - OS THERAPIES INC. (NYSE AMERICAN: OSTX) ("OS THERAPIES" OR "THE COMPANY"), A CLINICAL-STAGE CANCER IMMUNOTHERAPY AND ANTIBODY DRUG CONJUGATE BIOTECHNOLOGY COMPANY, TODAY ANNOUNCED ITS PARTICIPATION IN UPCOMING OCTOBER 2025 CONFERENCES AND EVENTS. CELL AND GENE MEETING ON THE MESA WHAT: PARTNERING AND ONE-ON-ONE MEETINGSWHEN: OCTOBER 6-8, 2025WHERE: ARIZONA BILTMORE, PHOENIX, AZWHO: PAUL ROMNESS, CHAIRMAN & CEOHOW: OS THERAPIES IS NOW A MEMBER OF THE ALLIANCE FOR REGENERATIVE MEDICINE ROTH ANNUAL HEALTHCARE OPPORTUNITIES CONFERENCE WHAT: MEETING PARTICIPATION AND ONE-ON-ONE MEETINGSWHEN: OCTOBER 9, 2025WHERE: METROPOLITAN CLUB, NEW YORK CITY, NYWHO: GERALD COMMISSIONG, CHIEF BUSINESS OFFICER FDA/THE OSTEOSARCOMA INSTITUTE (OSI) WORKSHOP: ADVANCING OSTEOSARCOMA DRUG DEVELOPMENT - CONNECTING RESEARCH AND REGULATORY PATHWAYS FOR IMPROVED OUTCOMES WHAT: MEETING PARTICIPATION AND AVAILABILITY FOR SIDELINE DISCUSSIONSWHEN: OCTOBER 10, 2025WHERE: LINCOLN SQUARE, WASHINGTON, DCWHO: OS THERAPIES MANAGEMENT & REGULATORY TEAM BIOFUTURE 2025 WHAT: SPOTLIGHT PANEL AND ONE-ON-ONE MEETINGSWHEN: OCTOBER 13-15, 2025WHERE: CURE, NEW YORK CITY, NYWHO: GERALD COMMISSIONG, CHIEF BUSINESS OFFICER 52ND DAYTIME EMMY AWARDS SHELTER ME: CANCER PIONEERS - NOMINATED FOR 2 EMMY'S TRAILER HERE MOVIE HERE WHAT: MAIN AWARDS PRESENTATION AND SELECT INVESTOR MEETINGSWHEN: OCTOBER 17, 2025WHERE: PASADENA CIVIC AUDITORIUM, PASADENA, CAWHO: PAUL ROMNESS, CHAIRMAN & CEO; GERALD COMMISSIONG, CHIEF BUSINESS OFFICER; NICOLA J.

OS THERAPIES TO PARTICIPATE IN FALL 2025 CONFERENCES AND EVENTS

GOUVERNEUR, N.Y., OCT. 07, 2025 (GLOBE NEWSWIRE) -- TITAN MINING CORPORATION (TSX:TI, OTCQB: TIMCF), (TITAN OR THE COMPANY) AN EXISTING ZINC CONCENTRATE PRODUCER IN UPSTATE NEW YORK AND AN EMERGING NATURAL FLAKE GRAPHITE PRODUCER, IS PLEASED TO ANNOUNCE THAT THE EXPORT-IMPORT BANK OF THE UNITED STATES (EXIM) HAS EXPRESSED FINANCING INTEREST OF UP TO US$120 MILLION UNDER ITS MAKE MORE IN AMERICA (MMIA) INITIATIVE FOR THE CONSTRUCTION OF TITAN'S WHOLLY OWNED KILBOURNE GRAPHITE PROJECT IN ST. LAWRENCE COUNTY, NEW YORK.

TITAN MINING RECEIVES FINANCING INTEREST OF UP TO US$120 MILLION FROM U.S. EXIM BANK FOR KILBOURNE GRAPHITE PROJECT

DALLAS--(BUSINESS WIRE)-- #ACTIVITIES--NEW YORK TIMES BESTSELLING AUTHOR LAURA NUMEROFF AND ILLUSTRATOR MASHA SUDOVYKH SPOTLIGHT THE SPECIAL BOND BETWEEN MOTHER AND SON IN THEIR NEW PICTURE BOOK, MAX AND MAMA (MICHAEL SAMPSON BOOKS; AVAILABLE NOW). SUDOVYKH'S WARMLY RENDERED CORGI ILLUSTRATIONS ARE THE PERFECT COUNTERPART TO NUMEROFF'S PLAYFUL WRITING STYLE, PAIRING EARLY CHILDHOOD LITERACY WITH CHRONOLOGICAL DAILY ACTIVITIES. MAX AND MAMA ENCOURAGES YOUNG READERS NOT TO GIVE UP; TO DISCARD THEIR TRAINING WH.

NEW YORK TIMES BESTSELLING AUTHOR OF IF YOU GIVE A MOUSE A COOKIE PUBLISHES CORGI PICTURE BOOK WITH MICHAEL SAMPSON BOOKS

NEW YORK--(BUSINESS WIRE)--THE NEW YORK TIMES COMPANY'S BOARD OF DIRECTORS TODAY DECLARED A REGULAR QUARTERLY DIVIDEND OF $.18 PER SHARE ON THE COMPANY'S CLASS A AND CLASS B COMMON STOCK. THE DIVIDEND IS PAYABLE ON OCTOBER 23, 2025, TO SHAREHOLDERS OF RECORD AS OF THE CLOSE OF BUSINESS ON OCTOBER 8, 2025. THE NEW YORK TIMES COMPANY (NYSE: NYT) IS A TRUSTED SOURCE OF QUALITY, INDEPENDENT JOURNALISM WHOSE MISSION IS TO SEEK THE TRUTH AND HELP PEOPLE UNDERSTAND THE WORLD. WITH MORE THAN 11 MILLION.

The New York Times Company

NYT

Price

Financials Overview

Financial Reports

No items found.

Press Releases

The New York Times Company

NYT.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

NYT